About This Conference
“Advances in the Management of Oncology, Stem Cell- and Solid Organ-Transplant Patients” provides attendees with comprehensive, accredited education involving the latest updates, emerging clinical technologies, and treatment trends in these highly complex fields of medicine.
Join OptumHealth Education as some of the nation’s leading clinicians identify the newest innovations in specialized areas of health care that include discoveries related to oncology, as well as hematopoietic stem cell and solid organ transplantation. Learn about the importance of kidney paired donation and the significant impact it has in live-donor kidney transplantation. Review management strategies for heart failure patients who are supported with left ventricular assist devices. Examine surgical considerations for patients with metastatic disease when determining the optimal timing and sequence of surgery and chemotherapy. Understand pharmacogenetics and the ethical, quality-of-life, cost, and outcomes issues that should be considered by both providers and patients when making informed treatment decisions. A panel of world-class clinical experts in transplant management, cardiac care, and oncology will address these and other hot topics.
Join Us for One, Two or All Three Days!
Participants are invited to create an agenda that best meets their specific needs by attending one, two or all three days of this conference. One area of medicine is covered each day—Monday, it will be solid organ transplantation; Tuesday, stem cell transplantation; and Wednesday, oncology.
This conference is designed to help health care professionals face the challenges of managing complex medical conditions in the fields of oncology and/or solid organ and stem cell transplantation.
Who Should Attend
- Case Managers
- Nurses/Oncology Nurses/Transplant Nurses
- Nurse Practitioners
- Managed Care Professionals
- Medical Directors
- Physician Assistants
- Social Workers
- Transplant Coordinators
- Hematopoietic Transplant Coordinators
- Medical Management Staff
- Reinsurance Managers
- Utilization Review Staff
- Other Health Care Professionals Committed to Managing and Improving Patient Care
* Refer to the Continuing Education page for a list of certifications that have been applied and/or approved for this conference.
Conference Educational Objectives
Upon successful completion of this conference, participants should be able to:
- Identify and relate the emerging trends in organ transplantation, focusing on the clinical and allocation considerations used for kidney, liver, intestine and lung.
- Examine the importance of understanding the ethical considerations involved in the organ allocation decision-making process, including: 1) quality-of-life issues; 2) costs; and 3) destination therapy in lieu of transplant.
- Relate how genetic counselors work as part of a health care team in conjunction with specially trained doctors, social workers, nurses, medical geneticists, and/or pharmacogenetics specialists in order to help patients and their families make informed decisions about their medical treatment and long-term health care management.
- Differentiate among the different types of stem cell transplant, determine which transplant type is appropriate for specific hematological diseases, and identify situations wherein the standard of care might vary for difficult diseases like acute myeloid leukemia or myelodysplastic syndrome.
- Recognize posttransplant complications that may require long-term therapy and management, including graft-versus-host disease, posttransplant infection, and secondary malignancy after transplant.
- Describe barriers to recovery that include metastatic disease, limited response to therapy, or difficulties with long-term pain management that limit patients’ quality of life and survivorship.
- Explain the unique considerations in treating childhood cancers and how health care management must change as children become adolescents, with an emphasis on the role of palliative care for pediatric patients.
- Discuss the surgical options for patients with metastatic disease, and describe the timing of chemotherapy administration in combination with surgical procedures.